Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients
Table 1
Comparison of demographic and baseline clinical characteristics between MACE and non-MACE groups.
MACE
NonMACE
P value
Age (years)
55.9 ± 17.3
58.2 ± 15.0
0.506
Male
14 (63.6%)
92 (74.8%)
0.277
Prior history
Hypertension
10 (45.5%）
69 (56.1%)
0.356
Diabetic mellitus
8 (36.4%)
38 (30.9%)
0.612
Prior myocardial infarction
4 (18.2%)
28 (22.8%)
0.784
Prior PCI or CABG
5 (22.7%)
12 (9.8%)
0.140
Chronic kidney disease
4 (18.2%)
20 (16.3%)
0.762
Clinical characteristics
HR (bpm)
98 (81,122)
84 (72,98)
0.011
MBP (mmHg)
82.8 (66.2, 88.3)
87.7 (70.4, 101.0)
0.060
Cr (mol/L)
89.1 (76.0, 133.8)
85.7 (70.1, 104.8)
0.215
TnI (ng/ml)
1.11 (0.07, 10.07)
0.07 (0.02, 1.45)
0.010
BNP (pg/ml)
973 (626,1889)
618 (203,1052)
0.004
LVEF (%)
31.4 ± 8.3
36.7 ± 8.1
0.006
LVEDD (mm)
60.5 (55.7, 73.2)
58.0 (52.0, 64.0)
0.065
EMATc
16.5 (14.0, 20.2)
12.7 (10.3, 15.0)
<0.001
Data are presented as mean ± standard deviation for continuous variables with normal distribution, as median (interquartile range) for continuous variables with skewed distribution, and as frequency (percentage) for categorical variables.
